Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. [electronic resource]
Producer: 20130827Description: 1345-9 p. digitalISSN:- 1545-5017
- Adolescent
- Adult
- Antilymphocyte Serum -- administration & dosage
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Female
- Follow-Up Studies
- Graft Rejection -- etiology
- Graft Survival
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunologic Factors -- administration & dosage
- Infant
- Male
- Myeloablative Agonists -- administration & dosage
- Retrospective Studies
- Risk Factors
- Survival Rate
- Tissue Donors
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Vidarabine -- administration & dosage
- beta-Thalassemia -- mortality
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.